Cancer: Drugs

Department of Health and Social Care written question – answered on 7th March 2018.

Alert me about debates like this

Photo of Jon Ashworth Jon Ashworth Shadow Secretary of State for Health and Social Care

To ask the Secretary of State for Health and Social Care, how many patients have received medicine funded by the Cancer Drugs Fund by medicine since 2016.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

Since the new Cancer Drugs Fund began in July 2016, just over 17,600 patients have been registered to receive treatment for 48 medicines.

Below is a table showing the breakdown by medicine.

Drug

Number

Atezolizumab

34

Bendamustine

2,321

Bevacizumab

1,595

Blinatumomab

29

Bortezomib

105

Bosutinib

39

Brentuximab

346

Cabozantinib

154

Carfilzomib

45

Ceritinib

15

Cetuximab

1,708

Clofarabine

82

Crizotinib

127

Daratumumab

35

Dasatinib

107

Eribulin

347

Everolimus

370

Ibrutinib

1,067

Ipilimumab/Nivolumab

97

Ixazomib

119

Lenvatinib

Fewer than 10

Nab-paclitaxel

134

Nelarabine

45

Nivolumab

541

Obinutuzumab

33

Olaratumumab

199

Osimertinib

255

Palbociclib

413

Panitumumab

392

Pemetrexed

37

Pembrolizumab

1,604

Pertuzumab

1,739

Pegylated liposomal doxorubicin

48

Pomalidomide

380

Ponatinib

88

Radium-223 Dichloride

243

Regorafenib

74

Ribociclib

29

Sorafenib

871

Sunitinib

71

Talimogene laherparepvec

Fewer than 10

Temsirolimus

Fewer than 10

Trastuzumab Emtansine

673

Trametinib/Dabrafenib

172

Trifluridine and tipiracil

444

Vandetanib

40

Venetoclax

118

Vismodegib

217

Source: NHS England. Information provided from 31 July 2016 to end of January 2018 (latest data available).

Note:

Numbers lower than 10 are rounded-up to avoid releasing potentially patient identifiable data, as per NHS England’s data protection commitments.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.